एपीए उद्धरण

Ehrhardt, M., Craveiro, R. B., Holst, M. I., Pietsch, T., & Dilloo, D. (2014). The PI3K inhibitor GDC-0941 displays promising in vitro and in vivo efficacy for targeted medulloblastoma therapy. Oncotarget.

शिकागो स्टाइल उद्धरण

Ehrhardt, Michael, Rogerio B. Craveiro, Martin I. Holst, Torsten Pietsch, और Dagmar Dilloo. "The PI3K Inhibitor GDC-0941 Displays Promising in Vitro and in Vivo Efficacy for Targeted Medulloblastoma Therapy." Oncotarget 2014.

एमएलए उद्धरण

Ehrhardt, Michael, et al. "The PI3K Inhibitor GDC-0941 Displays Promising in Vitro and in Vivo Efficacy for Targeted Medulloblastoma Therapy." Oncotarget 2014.